James Schurr, MD, PharmD (@schurr_james) 's Twitter Profile
James Schurr, MD, PharmD

@schurr_james

Fellow @PennCardiology || IM @PennIMResidents || Crit Care Rx @BrighamPharmacy || shock and hemodynamics aficionado || #rstats || opinions rare & my own

ID: 1486176116100501510

calendar_today26-01-2022 03:16:29

10 Tweet

88 Followers

186 Following

Frank Silvestry MD (@fsilvestrymd) 's Twitter Profile Photo

Welcoming an incredible group of incoming cardiology fellows to Penn Cardiology Penn Cardiology Fellows Penn Women in Cardiology PennCV_ARMI PennCVI . Thrilled to have you join in July! Looking at all the amazing match results today gives so much hope for the future of CV medicine! Congratulations!

Welcoming an incredible group of incoming cardiology fellows to <a href="/PennCardiology/">Penn Cardiology</a> <a href="/PennCVFellows/">Penn Cardiology Fellows</a> <a href="/PennCVWomen/">Penn Women in Cardiology</a> <a href="/PenncvARMI/">PennCV_ARMI</a> <a href="/PennCVI/">PennCVI</a> . Thrilled to have you join in July! Looking at all the amazing match results today gives so much hope for the future of CV medicine! Congratulations!
James Schurr, MD, PharmD (@schurr_james) 's Twitter Profile Photo

From our multicenter experience: 1. ECMO bridged patients are sicker than non-bridged IMACS 1 and have worse but acceptable 1yr survival (75% w/ HM3) (should ECMO be IMACS 0?) 2. HM3 recipients had improved survival Mike Genuardi, MD Michael Givertz Akram Zaaqoq Katelyn Sylvester